Journal of Peking University(Health Sciences) >
树栋 张 , 睿扬 谢 . [J]. Journal of Peking University(Health Sciences), 2024 , 56(4) : 562 -564 . DOI: 10.19723/j.issn.1671-167X.2024.04.002
| 1 | Marshall FF , Dietrick DD , Baumgartner WA , et al. Surgical management of renal cell carcinoma with intracaval neoplastic extension above the hepatic veins[J]. J Urol, 1988, 139 (6): 1166- 1172. |
| 2 | Reese AC , Whitson JM , Meng MV . Natural history of untreated renal cell carcinoma with venous tumor thrombus[J]. Urol Oncol, 2013, 31 (7): 1305- 1309. |
| 3 | Tilki D , Nguyen HG , Dall-Era MA , et al. Impact of histologic subtype on cancer-specific survival in patients with renal cell carcinoma and tumor thrombus[J]. Eur Urol, 2014, 66 (3): 577- 583. |
| 4 | 黄庆波, 彭程, 顾良友, 等. 肾肿瘤伴静脉瘤栓"301分级系统"及手术策略(附100例病例分析)[J]. 微创泌尿外科杂志, 2017, 6 (6): 328- 332. |
| 5 | Aslam-Sohaib SA , Teh J , Nargund VH , et al. Assessment of tumor invasion of the vena caval wall in renal cell carcinoma cases by magnetic resonance imaging[J]. J Urol, 2002, 167 (3): 1271- 1275. |
| 6 | Zargar-Shoshtari K , Sharma P , Espiritu P , et al. Caval tumor thrombus volume influences outcomes in renal cell carcinoma with venous extension[J]. Urol Oncol, 2015, 33 (3): 112. |
| 7 | Tabbara MM, Gonzalez J, Ciancio G. Renal cell carcinoma with supradiaphragmatic tumor thrombus: Avoiding sternotomy and cardiopulmonary bypass[J]. Med Res Arch, 2022(2022-07-31)[20230-1-15]. https://pubmed.ncbi.nlm.nih.gov/36714035. |
| 8 | Thiel DD , Lohse CM , Arnold ML , et al. Does left side renal cell carcinoma (RCC) with renal vein/vena cava thrombus predict worse prognosis than equivalent right side RCC tumor thrombus?[J]. Int Urol Nephrol, 2012, 44 (4): 1005- 1012. |
| 9 | Zhang Y , Bi H , Fu Y , et al. Cephalic inferior vena cava non-clamping technique versus standard procedure for robot-assisted laparoscopic level Ⅱ-Ⅲ thrombectomy: A prospective cohort study[J]. Int J Surg, 2023, 109 (6): 1594- 1602. |
| 10 | Cost NG , Delacroix SE , Jr. , Sleeper JP , et al. The impact of targeted molecular therapies on the level of renal cell carcinoma vena caval tumor thrombus[J]. Eur Urol, 2011, 59 (6): 912- 918. |
| 11 | Bigot P , Fardoun T , Bernhard JC , et al. Neoadjuvant targeted molecular therapies in patients undergoing nephrectomy and inferior vena cava thrombectomy: Is it useful?[J]. World J Urol, 2014, 32 (1): 109- 114. |
| 12 | Zhang Y , Li Y , Deng J , et al. Sorafenib neoadjuvant therapy in the treatment of high risk renal cell carcinoma[J]. PLoS One, 2015, 10 (2): e0115896. |
| 13 | Field CA , Cotta BH , Jimenez J , et al. Neoadjuvant sunitinib decreases inferior vena caval thrombus size and is associated with improved oncologic outcomes: A multicenter comparative analysis[J]. Clin Genitourin Cancer, 2019, 17 (3): e505- e512. |
| 14 | Stewart GD , Welsh SJ , Ursprung S , et al. A Phase Ⅱ study of neoadjuvant axitinib for reducing the extent of venous tumour thrombus in clear cell renal cell cancer with venous invasion (NAXIVA)[J]. Br J Cancer, 2022, 127 (6): 1051- 1060. |
| 15 | Zhang Z , Xiong L , Wu Z , et al. Neoadjuvant combination of pazopanib or axitinib and programmed cell death protein-1-activated dendritic cell-cytokine-induced killer cells immunotherapy may facilitate surgery in patients with renal cell carcinoma[J]. Transl Androl Urol, 2021, 10 (5): 2091- 2102. |
| 16 | Labbate C , Hatogai K , Werntz R , et al. Complete response of renal cell carcinoma vena cava tumor thrombus to neoadjuvant immunotherapy[J]. J Immunother Cancer, 2019, 7 (1): 66. |
| 17 | Hara T , Terakawa T , Hyodo T , et al. Pathological complete response of renal cell carcinoma with vena cava tumor thrombus to neoadjuvant TKI/IO combination therapy[J]. Urol Case Rep, 2021, 39, 101800. |
| 18 | Powles T , Tomczak P , Park SH , et al. Pembrolizumab versus placebo as post-nephrectomy adjuvant therapy for clear cell renal cell carcinoma (KEYNOTE-564): 30-month follow-up analysis of a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial[J]. Lancet Oncol, 2022, 23 (9): 1133- 1144. |
| 19 | Choueiri TK , Tomczak P , Park SH , et al. Adjuvant pembrolizumab after nephrectomy in renal-cell carcinoma[J]. N Engl J Med, 2021, 385 (8): 683- 694. |
| 20 | Wu Z , Chen H , Chen Q , et al. Prognostic significance of grade discrepancy between primary tumor and venous thrombus in nonmetastatic clear-cell renal cell carcinoma: Analysis of the REMEMBER registry and implications for adjuvant therapy[J]. Eur Urol Oncol, 2024, 7 (1): 112- 121. |
/
| 〈 |
|
〉 |